Godrej Appliances forayed into healthcare space by manufacturing medical refrigeration with transferred technology

The innovative product with patented technology can maintain precise temperature and work without electricity for 13 days, which may reduce wastage and help immunization programs


By Libin Chacko Kurian

Godrej Appliances, one of the leading players in the Home Appliances industry, in partnership with The UK based The Sure Chill Company, has launched the 'Godrej medical refrigerators with Sure Chill technology'. The specialised medical refrigerators have been designed especially to address a key need of providing precise cooling for preserving vaccines used worldwide in immunization programs and for the storage of blood in blood banks.

With manufacturing the appliances, the venture claims to support Make in India campaign, as Godrej Appliances becomes the only company which manufacture medical refrigeration in India and will also be exporting to more than 75 countries in near future. The manufacturing facilities in Mumbai and Pune have the capacity to produce 10,000 appliances annually, which will be upgraded to 30,000 soon. The company is in talks with the Nepal government to provide more than 100 such refrigerators for disaster relief in that country.

The company have already installed 13 refrigerators for medicinal purposes in West Bengal and is working since September 2014. 50 more refrigerators will be installed in four more states namely, Jharkhand, Uttar Pradesh, Uttarakhand and Meghalaya soon. Godrej appliances have the largest network with more than 500 service centres reaching every district in the country. The company is releasing an investment of 35 crores in three phases for the manufacturing of medical refrigeration, of which first phase is already in process.

Sure Chill's technology helps to maintain the optimum temperature range of 2 - 8 degrees Celsius - a necessity for vaccine preservation and blood storage. This refrigerator maintains its temperature even in case of power outages for as long as 8-12 days in ambient temperatures of 43˚C. In regions without electric supply, the system can be teamed with solar power to deliver the same results, thereby, making it fit for global immunisation needs.

Previous 1 3 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email